All studies
RecruitingOBSERVATIONAL

Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE)

This research project, called RAUCISABLE, is about making emergency digestive surgery safer and better for patients. It's part of a bigger programme that uses new ways of working, including smart technology and improved care plans, to help people who need urgent operations. The main goal of this particular study is to find the best way to identify which patients would benefit most from these new approaches in an emergency department. By doing this, the researchers hope to improve how patients are cared for and help predict the best treatment plans for them.

At a glance

Status
Recruiting
Sponsor
Centre Hospitalier Universitaire, Amiens
Enrolment target
300,000
Start
17 Jan 2025
Estimated completion
17 Jan 2026

What is this study about?

Imagine you need emergency surgery on your digestive system. This can be a stressful and serious time. Researchers at Amiens-Picardy University Hospital and the University of Picardy Jules Verne are working on something called the RAUC program, which aims to make this experience much smoother and safer for patients.

The RAUC program looks at lots of different ways to improve care. This includes using special care plans to help patients recover faster (called 'enhanced recovery programs'), using clever computer systems (artificial intelligence) to help doctors make decisions, making sure things run smoothly in the hospital, and even using connected devices to monitor patients. All of these things are designed to give patients the best possible care before, during, and after their emergency surgery.

This specific study, RAUCISABLE, is about making sure the right patients join the main RAUC program. It focuses on finding the best way to pick out people who would benefit most from these new methods. By doing this well, the researchers hope to improve how patients are managed and even create better predictions about what kind of care will work best for different individuals.

Key takeaways

  • This study aims to improve emergency surgery care.
  • It focuses on finding the best way to identify eligible patients.
  • It involves using smart technology and better care plans.
  • All adults visiting the emergency department are considered.
  • You can opt out if you don't want your data used for research.
  • Your medical treatment will not be changed by this study.

Who may be eligible?

To be considered for this study, you would need to be an adult, aged 18 or over. The study is looking at all patients who come into the emergency department.

There's a very simple reason why you might not be able to join: if you prefer that your health information isn't used for research, then you wouldn't be included. Your decision about your data is always respected.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you an adult (18 years or older)?
  2. Are you visiting the emergency department?
  3. Are you happy for your health information to be used for research to improve patient care?
  4. Do you understand that this study does not change your medical treatment?
Answer every question to see your result.

What does participation involve?

This study is about how patients are identified for care, rather than a clinical trial where you'd receive a new medication or treatment. It's focused on improving the hospital's process. Therefore, if you are eligible and come to the emergency department, your routine care might be part of the data being looked at to improve how other patients are identified for the RAUC program in the future. You wouldn't need to make extra visits, take specific medicines for the study, or have additional tests. The study is more about observing and improving existing hospital practices.

Potential risks and benefits

Since this study is about improving how patients are identified for care rather than direct treatment, the potential benefits are mainly for future patients who might receive improved care based on the findings. There are no direct personal medical benefits or risks associated with your individual participation, as it does not involve altering your medical treatment. The main 'risk' would be if you did not want your information to be considered for research purposes, which you always have the right to object to. You are free to withdraw your consent for your data to be used at any point without it affecting your medical care.

Locations (1)

  • CHU Amiens-Picardie
    Verified postcode
    Amiens, France· Recruiting

Common questions

What is the main goal of this study?

The main goal is to find better ways to identify patients in the emergency department who would benefit from special care during emergency surgery.

Will I receive a new treatment if I'm part of this study?

No, this study isn't about new treatments. It's about improving how the hospital identifies patients for existing special care programs.

Who can take part in this study?

Any adult (18 years or older) visiting the emergency department could be considered, unless they object to their data being used for research.

Will my care change if I'm in this study?

No, your medical care will not change because of this study. It's about observing and improving processes, not altering your treatment.

What if I don't want my information used?

You always have the right to object to your information being used for research. Your decision will be respected and will not affect your medical care.

How to find out more

Jean-Marc REGIMBEAU, MD

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Automatic Detection of Eligible Patients to RAUC Protocol (R…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.